RESUMO
INTRODUCTION: The effectiveness of bowel cleansing is a key element for high-quality colonoscopy. Recently, a 1â¯L polyethylene glycol plus ascorbate (PEG-ASC) solution has been introduced, but effectiveness and safety of this preparation have not been assessed in IBD patients. This study aims to evaluate effectiveness and safety of 1â¯L PEG-ASC solution in patients with IBD compared to controls. METHODS: We retrospectively analysed prospectively collected data on a cohort of 411 patients performing a colonoscopy after preparation with 1â¯L PEG-ASC, consecutively enrolled in 5 Italian centres. RESULTS: Overall, 185/411 (45%) were patients with IBD and 226/411 (55%) served as controls. A significantly higher cleansing success was achieved in IBD patients (92.9% vs 85.4%, pâ¯=â¯0.02). The multiple regression model showed that presence of IBD (OR=2.514, 95%CI=1.165-5.426; Pâ¯=â¯0.019), lower age (OR=0.981, 95%CI=0.967-0.996; Pâ¯=â¯0.014), split preparation (OR=2.430, 95%CI=1.076-5.492; Pâ¯=â¯0.033), absence of diabetes (OR=2.848, 95%CI=1.228-6.605; Pâ¯=â¯0.015), and of chronic constipation (OR=3.350, 95%CI=1.429-7.852; Pâ¯=â¯0.005), were independently associated with cleansing success. The number of treatment-emergent adverse events (TEAEs) (51â¯vs 62%, pâ¯=â¯0.821), and of patients with TEAEs (22.2% vs 21.2%, pâ¯=â¯0.821), were similar in IBD patients and in controls, respectively. CONCLUSIONS: Results from this study support the effectiveness and safety of 1â¯L PEG-ASC solution in IBD patients, which may improve the definition of endoscopic outcomes both in Crohn's disease and ulcerative colitis.
Assuntos
Ácido Ascórbico/análogos & derivados , Catárticos/administração & dosagem , Colite Ulcerativa/complicações , Colonoscopia/métodos , Doença de Crohn/complicações , Fosfatidiletanolaminas/administração & dosagem , Adulto , Ácido Ascórbico/administração & dosagem , Ácido Ascórbico/efeitos adversos , Catárticos/efeitos adversos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fosfatidiletanolaminas/efeitos adversos , Estudos RetrospectivosRESUMO
BACKGROUND: Over-prescribing in patients with respiratory tract infections is common in Australian hospitals. Senior registrar stewardship input within 24 h of admission in hospitalised patients was assessed to determine if this would improve appropriateness. METHODS: Interventional, non-randomised, case-controlled study over six-month period. Patients diagnosed with pneumonia admitted under General Medicine were discussed at morning handover and assessed by a senior registrar within the first 24 h of admission with real-time stewardship feedback provided. Controls did not receive stewardship advice. Appropriateness of antibiotic use was assessed using Therapeutic Guidelines. RESULTS: In total, 48 patients had an intervention with 49 controls. Ceftriaxone-based regimens were the most commonly prescribed (control 63%; pre-intervention 70%; post-intervention 51%). The senior registrar recommended changes in 26 patients (55%) with 71% uptake of recommendations. The most common recommendation was de-escalation from ceftriaxone-regimen in patients with CORB scores of 0 and 1 (79%; n = 16/20). Post-intervention antibiotic prescribing improved from <5% to 50% in patients with CORB scores of 0 and 1 (p-value <0.05). CONCLUSION: Our results demonstrate that involvement of a senior registrar embedded in the treating team is effective in providing timely advice to influence common hospital over-prescribing in patients with pneumonia. This enhances other antimicrobial stewardship activities such as electronic approval systems and dedicated post-prescribing rounds by Antimicrobial Stewardship team.
RESUMO
PURPOSE: The purpose of this study is to evaluate the usefulness of the design of experiments in the analysis of multiparametric problems related to the quality assurance in radiotherapy. The main motivation is to use this statistical method to optimize the quality assurance processes in the validation of beam models. METHOD: Considering the Varian Eclipse system, eight parameters with several levels were selected: energy, MLC, depth, X, Y1 and Y2 jaw dimensions, wedge and wedge jaw. A Taguchi table was used to define 72 validation tests. Measurements were conducted in water using a CC04 on a TrueBeam STx, a TrueBeam Tx, a Trilogy and a 2300IX accelerator matched by the vendor. Dose was computed using the AAA algorithm. The same raw data was used for all accelerators during the beam modelling. RESULTS: The mean difference between computed and measured doses was 0.1±0.5% for all beams and all accelerators with a maximum difference of 2.4% (under the 3% tolerance level). For all beams, the measured doses were within 0.6% for all accelerators. The energy was found to be an influencing parameter but the deviations observed were smaller than 1% and not considered clinically significant. CONCLUSION: Designs of experiment can help define the optimal measurement set to validate a beam model. The proposed method can be used to identify the prognostic factors of dose accuracy. The beam models were validated for the 4 accelerators which were found dosimetrically equivalent even though the accelerator characteristics differ.
Assuntos
Física Médica/métodos , Dosagem Radioterapêutica , Planejamento da Radioterapia Assistida por Computador , Algoritmos , Aceleradores de Partículas , Fótons , Fenômenos Físicos , RadiometriaRESUMO
Histioconductive approaches to soft-tissue defects use scaffolds seeded with lineage- and tissue-specific progenitors to generate tissue which should reside in equilibrium with adjacent tissue. Scaffolds guide histiogenesis by ensuring cell-cell and cell-matrix interactions. Hyaluronic acid-based (HA) preadipocyte-seeded scaffolds were evaluated for their adipo-conductive potential and efficacy in humans. Preadipocytes were isolated from lipoaspirate material and seeded on HA scaffolds. The cellular bio-hybrid (ADIPOGRAFT) and an acellular control scaffold (HYAFF11) were implanted subcutaneously. At specific time points (2, 8 and 16 weeks) explants were analyzed histopathologically with immunohistochemistry. No adverse tissue effects occurred. Volume loss and consistent degradation of the HYAFF11 scaffolds compared to the ADIPOGRAFT group indicated progressive tissue integration. No consistent histological differences between both groups were observed. By 8 weeks all void spaces within the scaffolds were filled with cells with pronounced matrix deposition in the ADIPOGRAFT bio-hybrids. Here we show that HA scaffolds were stable cell carriers and had the potential to generate volume-retaining tissue. However, no adipogenic differentiation was observed within the preadipocyte-seeded scaffolds.
Assuntos
Adipócitos , Técnicas de Cultura de Células , Ácido Hialurônico/química , Células-Tronco , Engenharia Tecidual/métodos , Alicerces Teciduais , Adipócitos/citologia , Adipócitos/fisiologia , Adulto , Diferenciação Celular , Células Cultivadas , Ensaios Clínicos como Assunto , Humanos , Ácido Hialurônico/metabolismo , Implantes Experimentais , Células-Tronco/citologia , Células-Tronco/fisiologia , Alicerces Teciduais/químicaRESUMO
CONTEXT: Oculopharyngeal muscular dystrophy (OPMD) is a rare myopathy caused by polyalanine triplet repeat expansion in the gene for poly(A) binding protein 2 (PABP2) and is found in isolated cohorts throughout the world. We have observed numerous cases of OPMD in New Mexico. OBJECTIVE: To characterize the clinical, genetic, and demographic features of the OPMD population in New Mexico. DESIGN, SETTING, AND PARTICIPANTS: Cohort study with analysis of outpatient clinic medical records from 1965 to 2001 at the University of New Mexico Hospital and the New Mexico VA Health Care System in Albuquerque, which serve the entire state. MAIN OUTCOME MEASURES: Clinical phenotype, supplemented with genetic confirmation (n = 10 patients) and in-depth clinical evaluations (n = 49 patients). RESULTS: We identified 216 cases of OPMD (99 women and 117 men) from 39 kindreds of New Mexicans spanning up to 4 generations. All patients were Hispanic, and the majority of probands came from northern New Mexico. In patients who had both ocular and pharyngeal muscle weakness, ptosis was just as likely to occur before or concurrent with dysphagia. Proximal limb muscle weakness and gait abnormalities were common and occurred later than ocular or pharyngeal weakness. The clinical expression of OPMD caused marked debility, although life-table analysis showed no decrease in life expectancy compared with unaffected family members (P =.81). Ten individuals from different kindreds were found to have an identical polyalanine triplet repeat expansion ([GCG](9)) in the PABP2 gene. CONCLUSIONS: Individuals in this cohort had clinical and genetic characteristics of classic OPMD. Longevity was not affected, but patients experienced considerable morbidity. The origin of the PABP2 mutation in New Mexican OPMD patients is unclear, although the geographic and genetic isolation of northern New Mexicans with a long ancestry in this region may have contributed to the development of this cohort. This disease cohort represents a large and previously unrecognized health care issue in the state of New Mexico and should serve to raise the awareness of this disorder among clinicians who treat Hispanics in the Southwest and throughout the United States.
Assuntos
Hispânico ou Latino/genética , Distrofias Musculares/etnologia , Adulto , Idoso , Proteínas de Ligação a DNA/genética , Feminino , Hispânico ou Latino/estatística & dados numéricos , Humanos , Tábuas de Vida , Masculino , Pessoa de Meia-Idade , Distrofias Musculares/diagnóstico , Distrofias Musculares/epidemiologia , Distrofias Musculares/genética , New Mexico/epidemiologia , Fenótipo , Proteína II de Ligação a Poli(A) , Expansão das Repetições de TrinucleotídeosRESUMO
We present a quantization of the Hamiltonian and diffeomorphism constraint of canonical quantum gravity in the spin network representation. The novelty consists in considering a space of wave functions based on the Vassiliev invariants. The constraints are finite, well defined, and reproduce at the level of quantum commutators the Poisson algebra of constraints of the classical theory. A similar construction can be carried out in 2+1 dimensions leading to the correct quantum theory.
RESUMO
Polymerase chain reaction (PCR) technique is widely used in the diagnosis of lymphoma, and PCR amplification products are typically detected by polyacrylamide gel electrophoresis (PAGE). However, the identification of small clonal populations, or the distinction of clonal PCR products in a polyclonal milieu remains difficult, requiring technically demanding alterations to gel analysis. This study describes an alternative approach using a capillary electrophoresis (CE) system to produce an accurately sized electropherogram. A variety of patient samples were examined, including solid tissue, peripheral blood, bone marrow aspirates, and paraffin-embedded tissue. A total of 28 samples were evaluated by PCR for B-cell clonality by detection of immunoglobulin heavy chain gene rearrangement and 29 samples for T-cell clonality by detection of T-cell gamma locus gene rearrangement. Standard 10% PAGE analysis of PCR products was compared with CE. There was a 100% concordance in the assessment of both B-cell and T-cell clonality. Dilution studies with the SUP-B15 cell line showed a detection limit of 0.03% for B-cell clonality and 0.05% for T-cell clonality using CE, versus 0.2% to 1%, respectively for PAGE. Automated, fluorescent analysis of PCR products by CE seems to be at least equally as effective as gel-based analysis for the detection of clonal B-cell and T-cell populations. Moreover. CE offers superior resolution and improved sensitivity, thus representing a significant improvement over traditional gel electrophoretic techniques in these regards.
Assuntos
Linfócitos B/citologia , Células Clonais/citologia , Eletroforese Capilar , Eletroforese em Gel de Poliacrilamida , Reação em Cadeia da Polimerase , Linfócitos T/citologia , Linfócitos B/química , Células Sanguíneas/química , Células Sanguíneas/citologia , Células da Medula Óssea/química , Células da Medula Óssea/citologia , Células Clonais/química , DNA/genética , Fluorometria , Rearranjo Gênico de Cadeia Pesada de Linfócito B , Rearranjo Gênico da Cadeia gama dos Receptores de Antígenos dos Linfócitos T , Neoplasias Hematológicas/sangue , Neoplasias Hematológicas/patologia , Humanos , Linfócitos do Interstício Tumoral/patologia , Neoplasias/sangue , Neoplasias/imunologia , Neoplasias/patologia , Células-Tronco Neoplásicas/química , Células-Tronco Neoplásicas/patologia , Inclusão em Parafina , Sensibilidade e Especificidade , Software , Linfócitos T/químicaRESUMO
This article summarizes the tremendous progress currently achieved in understanding the molecular basis of the pediatric acute leukemias. The article is organized from the perspective of the most frequently encountered pediatric acute leukemia genetic abnormalities in a molecular diagnostics laboratory setting. For each specific entity, the basic molecular biology, putative mechanisms of leukemogenesis, detection methods, and clinical significance are reviewed. Emphasis is placed on discussing the fusion genes generated from common nonrandom chromosomal translocations in B-lineage acute lymphoblastic leukemia (ALL), although brief summaries of T-lineage and myeloid leukemia, as well as the use of the antigen receptor gene rearrangement for residual disease monitoring in acute lympocytic leukemia are also presented. Finally, an overview of emerging technologies of potential importance in the laboratory diagnosis and evaluation of the pediatric acute leukemias is provided.
Assuntos
Aberrações Cromossômicas , Leucemia Mieloide Aguda/diagnóstico , Leucemia-Linfoma Linfoblástico de Células Precursoras/diagnóstico , Proto-Oncogenes , Fatores de Transcrição , Linfoma de Burkitt/diagnóstico , Linfoma de Burkitt/genética , Proteínas de Ligação a DNA/genética , Proteínas de Fusão bcr-abl/genética , Rearranjo Gênico , Genes myc , Histona-Lisina N-Metiltransferase , Humanos , Leucemia Mieloide Aguda/genética , Leucemia-Linfoma de Células T do Adulto/diagnóstico , Leucemia-Linfoma de Células T do Adulto/genética , Proteína de Leucina Linfoide-Mieloide , Neoplasia Residual , Leucemia-Linfoma Linfoblástico de Células Precursoras/genética , Translocação GenéticaRESUMO
Approximately 95% of all Friedreich's ataxia (FA) patients are homozygous for a large GAA triplet-repeat expansion in the first intron of the Friedreich's ataxia gene (FRDA). The remaining cases are expected to be compound heterozygous with a GAA expansion on one allele and a point mutation on the other. Generally, the clinical diagnostic profile in this group of patients is indistinguishable from that in classic FA patients with homozygous expansions. This study describes a mildly affected patient who presents with only one expanded allele by Southern blot analysis. Point mutation screening shows a single base change in FRDA exon 3 resulting in a nonconservative amino acid replacement in the N-terminal portion of the frataxin protein. Extended family studies show that two of the patient's sibs are carriers of the expanded allele and one is a carrier of the missense mutation. This case study demonstrates the benefits of implementing a combined Southern blot and point mutation diagnostic protocol for compound heterozygous patients. By identifying both mutations, this procedure confirms the diagnosis of FA in patients with an atypical disease course and allows for more complete family studies.
Assuntos
Ataxia de Friedreich/diagnóstico , Ataxia de Friedreich/genética , Mutação de Sentido Incorreto/genética , Adulto , Southern Blotting , DNA/análise , Análise Mutacional de DNA , Feminino , Testes Genéticos , Heterozigoto , Humanos , Linhagem , Expansão das Repetições de Trinucleotídeos/genéticaRESUMO
BACKGROUND: Hereditary hemochromatosis, a common autosomal recessive trait caused by mutations in the HLA-H gene, is often diagnosed by the pathologist at the time of histologic examination. Unfortunately, histologic parameters alone do not differentiate between hereditary hemochromatosis and other causes of iron overload. We performed a retrospective study to determine the frequency of familial hemochromatosis in patients diagnosed with he mochromatosis by abnormal liver histology. METHODS AND RESULTS: DNA was isolated from paraffin-embedded tissue sections from 15 patients and used in a polymerase chain reaction-based assay in which we tested for the C282Y and H63D mutations. We found that in this group of patients, 5 (33%) were homozygous for the common C282Y genetic mutation, 3 (20%) were heterozygous, and 7 (47%) were normal. CONCLUSIONS: Our study shows that the molecular assay is the gold standard for the diagnosis of hereditary hemochromatosis. The case study also illustrates that a definitive diagnosis of familial hemochromatosis has significant counseling implications allowing for accurate family studies.
Assuntos
Biópsia , Análise Mutacional de DNA , Hemocromatose/diagnóstico , Hemocromatose/genética , Hepatopatias/genética , Adulto , Idoso , Diagnóstico Diferencial , Eletroforese em Gel de Poliacrilamida , Feminino , Hemocromatose/patologia , Heterozigoto , Homozigoto , Humanos , Hepatopatias/patologia , Masculino , Pessoa de Meia-Idade , Mutação , Linhagem , Reação em Cadeia da PolimeraseRESUMO
Parasite immunologists had known for some time that IgE-mediated hypersensitivity reactions are rare in patients with chronic helminth infections, even though basophils and mast cells in these patients are sensitized with antiparasite IgE and exposed, often continuously, to parasite antigens. The inhibition of allergic reactivity in chronic helminth infections is mainly due to IgG4 'blocking antibodies' in the serum of the infected individual. IgG4 do not fix complement and bind weakly to Fcgamma receptors. Thus, antigen binding by IgG4, unlike IgE, is likely to have no or minimally harmful consequences. The discovery that, similar to IgE, expression of IgG4 is IL-4-dependent and is an intermediate step in sequential switching from IgM to IgE makes it imperative to understand how the two isotypes are coregulated and whether the two responses can be uncoupled, selectively boosting IgG4 over IgE. The ultimate goal is to apply to allergy the lesson we learnt from helminth infections.
Assuntos
Linfócitos B/imunologia , Imunoglobulina E/imunologia , Animais , Linfócitos B/efeitos dos fármacos , Humanos , Hipersensibilidade/imunologia , Switching de Imunoglobulina/efeitos dos fármacos , Imunoglobulina E/efeitos dos fármacos , Imunoglobulina G/efeitos dos fármacos , Imunoglobulina G/imunologia , Isotipos de Imunoglobulinas/efeitos dos fármacos , Isotipos de Imunoglobulinas/imunologia , Interleucina-4/farmacologiaRESUMO
The exon 45 deletion is a common dystrophin gene deletion. Although this is an out-of-frame deletion, which should not allow for protein synthesis, it has been observed in mildly affected patients. We describe a patient with an exon 45 deletion who produced protein, but still had a severe Duchenne muscular dystrophy phenotype. RT-PCR analysis and cDNA sequencing from the muscle biopsy sample revealed that the exon 45 deletion induced exon skipping of exon 44, which resulted in an in-frame deletion and the production of dystrophin. A conformational change in dystrophin induced by the deletion is proposed as being responsible for the severe phenotype in the patient. We feel that the variable clinical phenotype observed in patients with the exon 45 deletion is not due to exon splicing but may be the result of other environmental or genetic factors, or both.
Assuntos
Distrofina/genética , Mutação da Fase de Leitura , Distrofias Musculares/genética , Sequência de Bases , Criança , Deleção de Genes , Humanos , Masculino , Dados de Sequência Molecular , Distrofias Musculares/patologiaRESUMO
A Becker muscular dystrophy patient was found to have a single base substitution at the 5' end of intron 54. This single base substitution disrupts the invariant GT dinucleotide within the 5' donor splice site and was shown to cause an out of frame deletion of exon 54 during mRNA processing. This is predicted to produce a truncated dystrophin protein which is more consistent with a DMD phenotype. However, small quantities of normal mRNA are also transcribed and these are sufficient to produce a reduced amount of normal molecular weight dystrophin and give rise to a milder BMD phenotype. This indicates that a single base substitution at an invariant dinucleotide of the splice site consensus sequence may still allow read through of the message and allow the production of some normal protein. This shows that there are a greater number of possible intronic mutations that can lead to a mild phenotype and it also underlines the importance of performing cDNA analysis when screening for small gene alterations in the BMD patient population.
Assuntos
Mutação da Fase de Leitura , Distrofias Musculares/genética , Splicing de RNA/genética , Sequência de Bases , Western Blotting , Criança , Análise Mutacional de DNA , DNA Complementar/análise , Distrofina/análise , Distrofina/genética , Éxons , Humanos , Masculino , Dados de Sequência Molecular , RNA Mensageiro/análise , RNA Mensageiro/metabolismo , Transcrição GênicaRESUMO
Duchenne and Becker muscular dystrophies (DMD and BMD) are caused by defects in the dystrophin gene. About two-thirds of the affected patients have large deletions or duplications, which occur in the 5' and central portion of the gene. The nondeletion/duplication cases are most likely the result of smaller mutations that cannot be identified by current diagnostic screening strategies. We screened approximately 80% of the dystrophin coding sequence for small mutations in 158 patients without deletions or duplications and identified 29 mutations. The study indicates that many of the DMD and the majority of the BMD small mutations lie in noncoding regions of the gene. All of the mutations identified were unique to single patients, and most of the mutations resulted in protein truncation. We did not find a clustering of small mutations similar to the deletion distribution but found > 40% of the small mutations 3' of exon 55. The extent of protein truncation caused by the 3' mutations did not determine the phenotype, since even the exon 76 nonsense mutation resulted in the severe DMD phenotype. Our study confirms that the dystrophin gene is subject to a high rate of mutation in CpG sequences. As a consequence of not finding any hotspots or prevalent small mutations, we conclude that it is presently not possible to perform direct carrier and prenatal diagnostics for many families without deletions or duplications.
Assuntos
Distrofina/genética , Distrofias Musculares/genética , Mutação Puntual , Sequência de Bases , Análise Mutacional de DNA , Éxons , Humanos , Dados de Sequência Molecular , Ácidos Nucleicos Heteroduplexes/análise , Reação em Cadeia da Polimerase , Deleção de SequênciaRESUMO
A new strategy has been developed for rapid haplotype analysis based on an initial multiplex amplification of several polymorphic sites, followed by heteroduplex detection. Heteroduplexes formed between two different alleles are detected because they migrate differently than the corresponding homoduplexes in Hydrolink-MDE gel. This simple, rapid method does not depend on specific sequences such as restriction enzyme sites or CA boxes and does not require the use of isotope. This approach has been tested using commonly occurring polymorphisms spanning the dystrophin gene as a model. We describe the use of the method to assign the carrier status of females in Duchenne muscular dystrophy (DMD) pedigrees. The method may be used for other genetic diseases when mutations are unknown or there are few dinucleotide markers in the gene proximity, and for the identification of haplotype backgrounds of mutant alleles.